Segal, Who May Have Lupus, Gets Hearing on Prison Medical Leave

December 10, 2004

Separate emails using a comma.

A federal judge has scheduled a hearing over whether to allow convicted insurance mogul Michael Segal to leave a Chicago jail to seek medical treatment.

Lawyers for Segal, 62, said in court Wednesday that their client may have lupus. Several of Segal’s friends said they were willing to post up to $2 million in property on his behalf for bond.

Segal has received medical care in custody and should not be released because of “egregious behavior,” Assistant U.S. Attorney Virginia Kendall said, including selling off a number of assets before the government could get its hands on it. Prosecutors consider Segal a flight risk.

U.S. District Judge Ruben Castillo scheduled the hearing for Tuesday.

Segal, former owner and CEO of the Near North Insurance Brokerage, was convicted in June of 26 counts of racketeering, fraud, embezzlement and other charges after a trial in which prosecutors claimed he looted a restricted account at Near North Insurance Brokerage Inc. to finance a lavish lifestyle.

Segal faces up to 20 years in prison at a sentencing date scheduled for Jan. 19.

Copyright 2004 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Separate emails using a comma.
Subscribe Like this article?
Subscribe to our free email newsletter.

Latest Comments

  • December 14, 2004 at 8:23 am
    Bob says:
    Its a fact that some convicts die in prison due to illness. Perhaps Segal will be one of the next ones. So what?
  • December 13, 2004 at 4:39 am
    B E says:
    As the dad of a woman with severe lupus, I affirm that lupus is many times worse than being in some third-world stinkhole lockup. Let him run, the taxpayers are looking some h... read more
  • December 13, 2004 at 4:19 am
    Big Neil says:
    He should be entitled to the same care of any other inmate, no more, no less.
See all comments

Add a Comment

Your email address will not be published. Required fields are marked *

*

More News
More News Features